SHERIDAN, WYOMING – May 7, 2025 – Resmed (NYSE: RMD, ASX: RMD), a leading health technology company specializing in sleep, breathing, and home care, has announced the acquisition of VirtuOx, a prominent independent diagnostic testing facility (IDTF) focused on sleep, respiratory, and cardiac conditions. This strategic acquisition strengthens Resmed’s position in virtual care and reinforces its commitment to improving healthcare delivery by providing more accessible and coordinated care to patients and healthcare providers.
Strategic Expansion into Virtual Diagnostics
The integration of VirtuOx's advanced diagnostic capabilities will enable Resmed to offer faster, more flexible, and affordable testing options to patients, particularly those suffering from conditions like obstructive sleep apnea (OSA), which often go undiagnosed. By leveraging VirtuOx’s virtual testing platform, Resmed can reduce barriers to diagnosis, enabling a smoother, digital-first experience for patients. This streamlined approach helps ensure patients follow through on testing and treatment, ultimately improving adherence and outcomes.
“This is about creating a simpler, more connected pathway to care,” said Justin Leong, Chief Product Officer at Resmed. “By integrating VirtuOx’s diagnostic capabilities into our ecosystem, we can help accelerate the time between evaluation and treatment, reduce drop-off, and help more people access the life-changing benefits of therapy for sleep apnea and related conditions.”
Strengthening Healthcare Provider Partnerships
The acquisition will enhance Resmed’s partnerships with healthcare providers, helping to alleviate current bottlenecks in the diagnostic process. It also creates more opportunities to collaborate with home medical equipment providers to ensure patients begin treatment without delay. By offering integrated tools for care coordination and patient engagement, Resmed aims to improve the overall healthcare experience and outcomes for patients.
VirtuOx’s CEO, Steve Lica, commented, “VirtuOx and Resmed are aligned in our focus to simplify healthcare and expand access. Joining Resmed gives us the opportunity to scale our impact, reach and help more patients, and keep innovating on behalf of the providers and health systems we serve.”
Addressing the Growing Demand for Home-Based Care
The acquisition aligns with the increasing demand for home-based care, driven by digital innovation, convenience, and a growing awareness of the benefits of in-home health solutions. Resmed’s expanded capabilities will allow the company to explore adjacent healthcare areas such as insomnia, while deepening relationships with physicians, sleep labs, and home medical equipment providers.
As part of the acquisition, VirtuOx will continue to operate as a fully owned subsidiary of Resmed, maintaining its brand and leadership team in the near term. The VirtuOx team will continue to drive growth and innovation within the broader Resmed ecosystem.
Future Outlook
This acquisition enhances Resmed’s ability to offer a comprehensive suite of digital health solutions, positioning the company to better support patients and healthcare providers with connected, patient-centric care. Financial terms of the deal were not disclosed, as the acquisition is not expected to materially impact Resmed’s financial results.
Resmed’s commitment to redefining sleep health, in conjunction with VirtuOx’s cutting-edge diagnostic technology, marks a significant step forward in the company’s mission to empower millions of people to live healthier, happier lives.
For more information on Resmed’s innovative healthcare solutions, visit Resmed.com.